169 filings
Page 2 of 9
8-K
fcgbgowy6wn25ut5rnk
9 Jan 24
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
8:01am
8-K
vueb141oh 8tlvgmspr0
4 Jan 24
Other Events
4:04pm
424B5
rl08lxgbo9ge7
4 Jan 24
Prospectus supplement for primary offering
4:02pm
424B5
ve684smpdx
3 Jan 24
Prospectus supplement for primary offering
4:04pm
8-K
r506guq ag0o
3 Jan 24
January 2024 Corporate Presentation
8:04am
8-K
2lkb4k
11 Dec 23
Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition
6:02am
8-K
1pvov2h1i
7 Nov 23
Keros Therapeutics to Present at Upcoming Healthcare Conferences
8:01am
8-K
4y43ixk qu
6 Nov 23
November 2023 Corporate Presentation
8:11am
8-K
ogl6hcdj2c
6 Nov 23
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
8:01am
8-K
ahqw4q8tppr
4 Oct 23
Keros Therapeutics Presents Preclinical Data from its KER-065 Program at the 28th International Annual Congress of the World Muscle Society
8:01am
8-K
yecuushkukgzs ivirh
5 Sep 23
Keros Therapeutics to Present at Upcoming Healthcare Conferences
8:02am
8-K
ti2fm9 1bgjj74
7 Aug 23
August 2023 Corporate Presentation
4:02pm
8-K
vuz88q55c
7 Aug 23
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
8:00am
8-K
2scr47iu
24 Jul 23
Other Events
8:01am
8-K
fws7aa tbt39b
9 Jun 23
Other Events
6:02am
8-K
uukn7o8vr1rjg o4bim
7 Jun 23
Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
8:01am
8-K
xyqb27xb6vye7y 1p
6 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
t22t6c8a28diq p1od
22 May 23
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
9:01am